Journey Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DERM and other ETFs, options, and stocks.About DERM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend.
CEOClaude Maraoui
CEOClaude Maraoui
Employees41
Employees41
HeadquartersScottsdale, Arizona
HeadquartersScottsdale, Arizona
Founded2014
Founded2014
Employees41
Employees41
DERM Key Statistics
Market cap215.19M
Market cap215.19M
Price-Earnings ratio-21.60
Price-Earnings ratio-21.60
Dividend yield—
Dividend yield—
Average volume145.86K
Average volume145.86K
High today$8.14
High today$8.14
Low today$7.78
Low today$7.78
Open price$7.89
Open price$7.89
Volume100.47K
Volume100.47K
52 Week high$9.40
52 Week high$9.40
52 Week low$3.54
52 Week low$3.54
Stock Snapshot
As of today, Journey Medical(DERM) shares are valued at $7.93. The company's market cap stands at 215.19M, with a P/E ratio of -21.60.
As of 2025-12-07, Journey Medical(DERM) stock has fluctuated between $7.78 and $8.14. The current price stands at $7.93, placing the stock +2.0% above today's low and -2.6% off the high.
Journey Medical(DERM) shares are trading with a volume of 100.47K, against a daily average of 145.86K.
During the past year, Journey Medical(DERM) stock moved between $3.54 at its lowest and $9.40 at its peak.
During the past year, Journey Medical(DERM) stock moved between $3.54 at its lowest and $9.40 at its peak.
People also own
Based on the portfolios of people who own DERM. This list is generated using Robinhood data, and it’s not a recommendation.